US Patent 10618912 Diaryl macrocycles as modulators of protein kinases
Patent 10618912 was granted and assigned to Turning Point Therapeutics on April, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10618912 Diaryl macrocycles as modulators of protein kinases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
